Lightcalls.com
 

Garlic "may be the best example of ...

Garlic "may be the best example of the continuum between plants as fare and plants as medicine," Donald J Brown ND announces in his late book Herbal Prescriptions for Better Health (Prima, 1996) He continues, "One of the in the greatest degree ancient remedies known to humanity, garlic, is a staple in the diets of an incredibly diverse number of agricultures Most of these cultures use garlic for medicinal purposes" Today, late research is finally confirming what ancient civilizations have known all along: garlic is a powerful healer.

Across the globe, countries are setting a garlic-eating example

When scientists compare cancer rates between garlic-loving countries, and countries that eschew this tasty (but pungent) spice, a clear pattern issues which links garlic with a lower risk of cancer. Early studies first showed this link in China, when researchers noticed that a certain region of this rural parts had both an extraordinarily high garlic intake and a surprisingly depressed rate of stomach cancer.

Chinese garlic-lovers are not the merely ones to benefit from garlic's cancer-fighting abilities. John Milner, Phd from Pennsylvania State University, points not at home in a review article tracking the anti-cancer efficiencys of garlic that "the potential benefits of garlic appear not to be limited to a specific region of the world because a similar inverse relationship is observ in residents of China, Italy, Germany, and the United States."



Aside from stomach cancer, following research suggests that high-garlic intakes lower the risk of esophageal and colon cancers. Now, a just discovered study adds another type of cancer to garlic's hit list: bladder cancer.

Garlic battles bladder cancer

Approximately 50000 strange cases of bladder cancer are diagnosed each year, with four times as many men compared to women falling victim to the disease. Environmental factors play a big part in cancer of the bladder. Smoker and industrial workers (including the color chemical, leather, and rubber industries) accompany to be the most likely targets of this cancer.

the same of the first-line treatments for bladder cancer is an immunotherapy put drugs into called Bacillus Calmette-Guerin (BCG). Although BCG is an effective treatment, its use is limited because it oftentimes triggers toxic side effects. This is to what end Donald Lamm, M.D., and colleagues from the Department of Urology West Virginia University instruct of Medicine, suggest that alternative therapies for bladder cancer are greatly needed

Considering its track record as a folk healer, Lamm suspected that garlic might fit the bill as an alternative bladder cancer therapy. To find revealed whether his assumption was in succession the mark, he designed a series of animal experiments in which a therapeutic supply of garlic was included (at various dosages) in the drinking water of 100 mice for common month before and two month after they were injected with bladder cancer cells

Tumor-growth slowed with garlic intake -- and with no side effects

grave doses of garlic slowed tumor vegetation by 37 percent, while the highest dose of garlic accrueed in an impressive 59 percent inhibition of tumor pullulation The garlic-spiked water also lengthened the life span of the mice with cancer. The mice with the greatest garlic intake were also the chiefly likely to survive the cancer.

Although BCG out-performed the garlic -- in denominations of blocking the growth of tumors and increasing survival rates -- the side purports this medication causes in populace limits its actual use for the bulk of mankind with bladder cancer. Garlic, in succession the other hand, has significant anti-tumor actions without this risk of side powers Lamm doesn't suggest that garlic be used exclusively for treating bladder cancer, if it were not that it does look promising as part of an overall treatment plan.

As The Official Garlic Lover's Handbook says of garlic, "The more you do to it, the more it will do to you." Garlic, in all of its forms (raw, tamper withed or odor-controlled supplements), can be used effectively according to all of us.

REFERENCES

Milner, J.A. "Garlic: Its anticarcinogenic and antitumorigenic properties," Nutrition Reviews 54(11):S82-S86 1996

Riggs, DR DeHaven J.I., and Lamm DL "Allium sativum (garlic) treatment for murine transitional solitary abode; squalid carcinoma," Cancer 79: 1987-94, 1997

COPYRIGHT 1997 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2004 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.